Evidence map›Paper›PMID 35173507›Full record

ReviewClinical medicine insights. Circulatory, respiratory and pulmonary medicine2020

Comprehensive Literature Review and Evidence evaluation of Experimental Treatment in COVID 19 Contagion.

Umesha Boregowda, Darshan Gandhi, Nitin Jain, Kanika Khanna, Nishant Gupta

Open access · goldAbstract readReview
In one paragraph

Review in Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Umesha BoregowdaDepartment of Internal Medicine, Bassett Medical Center, Cooperstown, NY, USA.
Darshan GandhiDepartment of Diagnostic Radiology, St. Vincent's Medical Center at Hartford Healthcare, Bridgeport, CT, USA.ORCID https://orcid.org/0000-0002-7079-450X
Nitin JainDepartment of Diagnostic Radiology, Ascension St. John Macomb and Oakland Hospitals, Warren & Madison Heights campuses, Troy, MI, USA.
Kanika KhannaDepartment of Radiology, Abdominal Imaging, Wayne State University School of Medicine, Henry Ford Hospital, Detroit, MI, USA.
Nishant GuptaDepartment of Radiology, Bassett Healthcare, Cooperstown, NY, USA.
Bassett Healthcare Network · USBassett Medical Center · USSt. John Macomb Oakland Hospital · USSt. Vincent's Medical Center · USWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

importanceCoronavirus 2019 pandemic (COVID 19) is caused by the Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) virus. The pandemic is affecting the livelihood of millions of people all over the world. At the time of preparing this report, the pandemic has affected 1 827 284 patients, with 113 031 deaths in 185 countries as per Johns Hopkins University. With no proven treatment for the disease, prevention of the disease in the community and healthcare setting is need of the hour.

objectiveTo perform a comprehensive literature search for preventive measures and experimental treatment options. In this review, we have focused our discussion on the risk of disease transmission, supportive treatment, and possible treatment options based on available evidence. EVIDENCE REVIEW: We performed a literature search on google scholar, PubMed, and society guidelines for literature related to COVID 19 and previous coronavirus pandemics. We included data review articles, observational studies, and controlled trials to synthesize the treatment options for COVID 19.

findingsIn this article, we have extensively reviewed and discussed recommendations from various world organizations for the public and healthcare workers. We have also discussed currently available experimental treatments since there is no proven treatment for COVID 19. The best method of dealing with the current outbreak is to reduce the community spread and thus "flatten the curve." Although Hydroxychloroquine, Remdesivir, Lopinavir/Ritonavir, and Azithromycin have been tried, passive immunity through convalescent serum and vaccine is still at an experimental stage. Patients with severe COVID 19 infections could be considered for this experimental treatment through various national randomized control trials, which may eventually lead to an evidence-based treatment strategy. CONCLUSIONS AND RELEVANCE: Awareness of currently available experimental treatment among healthcare providers and exploration of possible treatment options through evidence is need of the hour. We have discussed the most recently available literature and evidence behind experimental treatment in this article.

Indexed as

coronavirusCOVID-19pandemicRemdesivirRT-PCRWuhan

Identifiers

PMID35173507
PMCPMC8842399
OpenAlexW3093600704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.